Answers are grounded in this paper and cite their sources.
Progressive supranuclear palsy (PSP) is a neurodegenerative tauopathy characterized by supranuclear gaze palsy, postural instability, axial rigidity, and executive dysfunction. Disturbances in cognition and behavior are core features of PSP and may precede the onset of overt motor symptoms. Here we describe a 56-year-old woman who was first managed for treatment-resistant depression and treated with repetitive transcranial magnetic stimulation (rTMS), after which she exhibited severe recurrent suicidal behavior. Further neurological assessment led to a diagnosis of PSP. This case highlights the diagnostic challenges posed by neuropsychiatric presentations of PSP and the difficulty of interpreting clinical change occurring after neuromodulatory treatment in the context of an evolving neurodegenerative disorder.
No takes yet. Share an insight, caveat, or question.
George et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: